Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study.

Honghu TangBeibei CuiYiyu ChenLin ChenZhihong WangNing ZhangYanlan YangXiaodong WangXiangliang XieLingyun SunWantai DangXianyang WangRunzi LiJianjun ZouYi ZhaoYi Liu

Published in: Therapeutic advances in musculoskeletal disease (2022)

www.chinadrugtrials.org.cn; CTR 20192429.

Keyphrases

phase ii study
double blind
placebo controlled
clinical trial
phase iii
phase ii
open label
study protocol
lymph node metastasis
uric acid
locally advanced
squamous cell carcinoma
randomized controlled trial
radiation therapy
rectal cancer